Noor Mruwat

Nahariyya, Z, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

The Risk of Immune-Mediated Skin Disease Under Dipeptidyl-Peptidase IV Inhibitor: A Global Population-Based Study.

The Risk of Immune-Mediated Skin Disease Under Dipeptidyl-Peptidase IV Inhibitor: A Global Population-Based Study.

Journal: International journal of dermatology

Published: April 06, 2025

Facultatively Anaerobic Staphylococci Enable Anaerobic Cutibacterium Species to Grow and Form Biofilms Under Aerobic Conditions.

Facultatively Anaerobic Staphylococci Enable Anaerobic Cutibacterium Species to Grow and Form Biofilms Under Aerobic Conditions.

Journal: Microorganisms

Published: November 20, 2024

The risk of different subtypes of psoriasis following an episode of guttate psoriasis.

The risk of different subtypes of psoriasis following an episode of guttate psoriasis.

Journal: Journal of the American Academy of Dermatology

Published: October 30, 2023

Reply to: 'Comment on Kridin et al.-Considering both relative and absolute risk differences in infection risk between biologics classes in patients with psoriasis'.

Reply to: 'Comment on Kridin et al.-Considering both relative and absolute risk differences in infection risk between biologics classes in patients with psoriasis'.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: September 29, 2023

Are interleukin 17 and interleukin 23 inhibitors associated with malignancies?-Insights from an international population-based study.

Are interleukin 17 and interleukin 23 inhibitors associated with malignancies?-Insights from an international population-based study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 05, 2023

Evaluating the risk of infections under interleukin 23 and interleukin 17 inhibitors relative to tumour necrosis factor inhibitors - A population-based study.

Evaluating the risk of infections under interleukin 23 and interleukin 17 inhibitors relative to tumour necrosis factor inhibitors - A population-based study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: January 07, 2023

Risk of infections in patients with pemphigus treated with rituximab vs. azathioprine or mycophenolate mofetil: a large-scale global cohort study.

Risk of infections in patients with pemphigus treated with rituximab vs. azathioprine or mycophenolate mofetil: a large-scale global cohort study.

Journal: The British journal of dermatology

Published: December 04, 2022

Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.

Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.

Journal: JAMA dermatology

Published: November 30, 2022

The cardiometabolic safety of interleukin 23 versus interleukin 17 inhibitors in psoriasis: A large-scale global cohort study.

The cardiometabolic safety of interleukin 23 versus interleukin 17 inhibitors in psoriasis: A large-scale global cohort study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: October 04, 2022

Mortality in eight autoimmune bullous diseases: A global large-scale retrospective cohort study.

Mortality in eight autoimmune bullous diseases: A global large-scale retrospective cohort study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: August 21, 2022

A single-cell polony method reveals low levels of infected Prochlorococcus in oligotrophic waters despite high cyanophage abundances.

A single-cell polony method reveals low levels of infected Prochlorococcus in oligotrophic waters despite high cyanophage abundances.

Journal: The ISME journal

Published: March 07, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026